|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Naming and outline of Dothideomycetes-2014 including proposals for the protection or suppression of generic names显示文摘Article 59.1,of the International Code of Nomenclature for Algae,Fungi,and Plants(ICN;Melbourne Code),which addresses the nomenclature of pleomorphic fungi,became effective from 30 July 2011.Since that date,each fungal species can have one nomenclaturally correct name in a particular classification.All other previously used names for this species will be considered as synonyms.The older generic epithet takes priority over the younger name.Any widely used younger names proposed for use,must comply with Art.57.2 and their usage should be approved by the Nomenclature Committee for Fungi(NCF).In this paper,we list all genera currently accepted by us in Dothideomycetes(belonging to 23 orders and 110 families),including pleomorphic and nonpleomorphic genera.In the case of pleomorphic genera,we follow the rulings of the current ICN and propose single generic names for future usage.The taxonomic placements of 1261 genera are listed as an outline.Protected names and suppressed names for 34 pleomorphic genera are listed separately.Notes and justifications are provided for possible proposed names after the list of genera.Notes are also provided on recent advances in our understanding of asexual and sexual morph linkages in Dothideomycetes.A phylogenetic tree based on four gene analyses supported 23 orders and 75 families,while 35 families still lack molecular data. | Nalin N.Wijayawardene Pedro W.Crous Paul M.Kirk David L.Hawksworth Saranyaphat Boonmee Uwe Braun Dong-Qin Dai Melvina J.D’souza Paul Diederich Asha Dissanayake Mingkhuan Doilom Singang Hongsanan E.B.Gareth Jones Johannes Z.Groenewald Ruvishika Jayawardena James D.Lawrey Jian-Kui Liu Robert Lücking Hugo Madrid Dimuthu S.Manamgoda Lucia Muggia Matthew P.Nelsen Rungtiwa Phookamsak Satinee Suetrong Kazuaki Tanaka Kasun M.Thambugala Dhanushka N.Wanasinghe Saowanee Wikee Ying Zhang Andre Aptroot H.A.Ariyawansa Ali H.Bahkali D.Jayarama Bhat Cécile Gueidan Putarak Chomnunti G.Sybren De Hoog Kerry Knudsen Wen-Jing Li Eric H.C.McKenzie Andrew N.Miller Alan J.L.Phillips Marcin Piatek Huzefa A.Raja Roger S.Shivas Bernad Slippers Joanne E.Taylor Qing Tian Yong Wang Joyce H.C.Woudenberg Lei Cai Walter M.Jaklitsch Kevin D.Hyde | 2014 | Fungal Diversity2014，，6： | 2 |
| 2 | Concurrent radiotherapy, paclitaxel and dose escalating carboplatin in the treatment of cervical cancer-a phase Ⅰ study显示文摘 | Addeo D Blank S Muggia F | 2008 | Anlicancer Res2008，28，5： | 1 |
| 3 | Overview of cancer-related hypercalcemia: epi- dermiologyand etiology显示文摘 | Muggia FM | 1990 | Semin Onco11990，17，25： | 1 |
| 4 | Revisiting Photobiont Diversity in the Lichen Family Verrucariaceae(Ascomycota)显示文摘 | Thüs H Muggia L Pérez-Ortega S | 2011 | Eur J Phycol2011，46，4： | 1 |
| 5 | PhaseⅢrandomized study of cisplatin versus paclitaxel versus cisplatin and paclitaxel in patients with suboptimal stageⅢorⅣovarian cancer:a gynecologic oncology group study显示文摘 | Muggia FM Braly PS Brady MF | 2000 | J Clin Oncol2000，18，1： | 1 |
| 6 | Phase I and pharrnacologic evaluation of intraperitoneal 5-fluoro-2'-deoxyuridine 显示文摘 | Muggia FM Chan KK Russell C | 1991 | Cancer Chemother Pharmacol1991，28，： | 1 |
| 7 | A phase Ⅱstudy of liposomal lurtotecan (OSI-211)in patients with topotecan resistant ovarian cancer 显示文摘 | Seiden MV Muggia F Astrow A | 2004 | Glynecol Oncol2004，93，1： | 1 |
| 8 | Cisplatin update显示文摘 | Muggia FM | 1991 | Semin Oncol1991，18，： | 1 |
| 9 | Overview of cancer-related hypercalcemia : epidemiology and etiology 显示文摘 | Muggia FM | 1990 | Semin Oncol1990，17，25： | 1 |
| 10 | BRCA genes:lessons learned from experimental and clinical cancer显示文摘 | Muggia F Safra T Dubean L | | 0，，1： | 1 |
| 11 | Complement activation by cremophor EL as a possible contributor to hypersensitivity to paclitaxel:an in vitro study显示文摘 | Szebeni J Muggia FM Alving CR | 1998 | J Natl Cancer Ins1998，90，4： | 1 |
| 12 | Paelitaxel-Induced Apoptosis and Mitotic Arrest Assessed by Serial Fine-Needle Aspiration : Implications for Early Prediction of Breast Cancer Response to Neoadjuvant Treatment 显示文摘 | SYMMANS W F VOLM M D SHAPIRO R L PERKINS A B KIM A Y DEMARIA S YEE H T MCMULLEN H ORATZ R KLEIN P FORMENTI S C MUGGIA F | 2000 | Clin Cancer Res2000，6，12： | 1 |
| 13 | Complement Activation by Cremophor EL as a Possible Contributor to Hypersensitivity to Paclitaxel: An in Vitro Study 显示文摘 | Szebeni J Muggia FM Alving CR | 1998 | Journal of The National Cancer Institute1998，90，4： | 1 |
| 14 | Complement activation by Ctemophor EL as a possible contributor to hypersensitivity to Paclilaxel:an in vitro study显示文摘 | SZEBENI J MUGGIA F M AI VING C R | 1998 | J Natl Cancer Inst1998，90，4： | 1 |
| 15 | Complement activation by Cremophor EL as a possible contributor to hypersensitivity to paclitaxel: an in vitro study 显示文摘 | Szebeni J Muggia FM Alving CR | 1998 | J Natl Cancer Inst1998，90，4： | 1 |
| 16 | Phase Ⅱ study of liposomal doxorubicin in refractory ovarian cancer: antitu- mor activity and toxicity modification by liposomal encapsulation 显示文摘 | MUGGIA F M HAINSWORTH J D JEFFERS S | 1997 | J Clin Oncol1997，15，3： | 1 |
| 17 | Epidermal growth factor receptor inhibitors for the treatment of epithelial ovarian cancer显示文摘 | Blank SV Chang R Muggia F | 2005 | Oncology2005，19，4： | 1 |
| 18 | A phase Ⅱ study of liposomal lurtotecan(OSI-211)in patients with topotecan resistant ovarian cancer显示文摘 | Seiden MV Muggia F Astrow A | 2004 | Glynecol Oncol2004，93，1： | 1 |
| 19 | Paclitaxe 13 - hourinfusion given alone and combined with Carboplatin:Preliminary results of dose - escalation trials显示文摘 | Muggia FM Vafai D Natale R | 1995 | Semin Oncol1995，22，9： | 1 |
| 20 | Complement activation by Cremophor EL as a possible contributor to hypersensitivity to paclitaxel:An in vitro study显示文摘 | Szebeni J Muggia FM Alving CR | 1998 | J Natl Cancer Inst1998，90，4： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员